Navigation Links
Medarex Reports Phase 1/2 Clinical Data of MDX-060 in Lymphoma at American Association for Cancer Research Meeting
Date:4/16/2008

PRINCETON, N.J., April 16 /PRNewswire-FirstCall/ -- Medarex, Inc. (Nasdaq: MEDX) announced today data from a Phase 1/2 trial that suggest a potential association between higher doses of MDX-060, an investigational anti-CD30 antibody, and improvement in disease control and prolonged progression-free survival in patients with relapsed or refractory CD30- positive lymphomas. Results from the Phase 1/2 trial were presented at the Annual Meeting of the American Association for Cancer Research (AACR), being held April 12-16, 2008 in San Diego (Abstract #5525).

"We continue to assess the potential for anti-CD30 antibody therapies in the marketplace and are pleased with the findings of this exploratory study," said Howard H. Pien, President and CEO of Medarex. "We look forward to analyzing these results alongside the Phase 2 proof-of-concept chemotherapy combination data that is expected later in the year."

In the completed dose-escalation Phase 1/2 trial, 72 patients with relapsed or refractory CD30-positive lymphoma received weekly doses of MDX-060 (0.1, 1, 4, 10 or 15 mg/kg) for four weeks. Of the 33 patients treated at the two highest doses of MDX-060, disease control was observed in 51 percent of patients (3 complete responses, 14 stable disease), with median progression- free survival of 3.7 months and 39 percent of patients with no evidence of disease progression four months post-treatment. Of the 39 patients treated at the three lowest doses of MDX-060, disease control was observed in 33 percent of patients (1 complete response, 2 partial responses, 10 stable disease), with median progression-free survival of less than 2 months and 18 percent of patients with no evidence of disease progression four months post-treatment. MDX
'/>"/>

SOURCE Medarex, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Medarex to Present at Thomas Weisel Partners Healthcare Conference 2007
2. Medarex to Present at the Bear Stearns 20th Annual Healthcare Conference
3. Medarex Announces Extension of Broad Antibody Development Relationship with Centocor
4. Medarex to Present at the A.G. Edwards 2nd Annual Emerging Growth Conference
5. Medarex to Present at the UBS Global Life Sciences Conference
6. Medarex Announces Election of Marc Rubin as New Board Member
7. Medarex to Present at the 26th Annual JPMorgan Healthcare Conference
8. Medarex Announces Completion of Sale of Shares in Genmab A/S
9. Medarex to Announce 2007 Fourth Quarter and Year-End Financial Results on Tuesday, February 26, 2008
10. Medarex to Present at the Susquehanna Financial Group Healthcare Conference
11. Medarex Announces Presentations at Annual Meeting of the American Association for Cancer Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... to perform fill/finish of nimotuzumab - , MISSISSAUGA, ... and CEO of YM BioSciences Inc. and Thomas ... today announced the signing of an agreement under ... services for nimotuzumab, the humanized monoclonal antibody licensed ... by the Centre of Molecular Immunology (CIM). Under ...
(Date:12/17/2009)... Screening allows users to easily find and schedule an appointment ... a health screening, share comments, view personal stories, and connect ... health screening company’s new site will improve its ... ... Cleveland, OH (PRWEB) December 17, 2009 -- Visitors to Life ...
(Date:12/16/2009)... has passed as fact among historians, journalists and politicians, ... the floor of the U.S. Congress: British forces used ... , But that claim has never been fully ... a historian at Colgate University. According to Douglas,s research, ... of Modern History , no such incident ever occurred. ...
(Date:12/16/2009)... cause of death from roadside bombs to freeway crashes. ... age 4 to 44, often overwhelms the body,s natural ... natural process, a team led by Erin Lavik, a ... her former doctoral student, James P. Bertram, built synthetic ... bleeding., Their work is published in Science Translational ...
Breaking Biology Technology:YM BioSciences Inc. and Therapure Biopharma Inc. Announce Contract 2YM BioSciences Inc. and Therapure Biopharma Inc. Announce Contract 3YM BioSciences Inc. and Therapure Biopharma Inc. Announce Contract 4Website Redesign Enhances Global Health Screening Service's Online Presence 2Website Redesign Enhances Global Health Screening Service's Online Presence 3Despite claims, UK did not gas Iraqis in the 1920s, new research finds 2Despite claims, UK did not gas Iraqis in the 1920s, new research finds 3Despite claims, UK did not gas Iraqis in the 1920s, new research finds 4Researchers take the inside route to halt bleeding 2
... Georgia led by postdoctoral associate Giel van Dooren has discovered a protein ... work points the way toward a new model system that can be ... an effective target for drug intervention. , ... Athens, GA (Vocus) February ...
... Data from the Mars Reconnaissance Orbiter (MRO) ... sites where life forms may have evolved on Mars, according ... peer-reviewed journal published by Mary Ann Liebert, Inc. ... at www.liebertpub.com/ast Hot springs have great astrobiological significance, as ...
... for the quarter decrease 17% vs. prior year -DENVER, Feb. ... worldwide developer and marketer of diagnostic test kits, today filed ... report disclosed that the company,s sales and operating results have ... 2008. Some of the results highlighted by the report are ...
Other Biology Technology:Researchers at the University of Georgia Discover Protein is Crucial to Reproduction of Parasites Involved in Disease 2Researchers at the University of Georgia Discover Protein is Crucial to Reproduction of Parasites Involved in Disease 3Evidence of Ancient Hot Springs on Mars Detailed in Astrobiology Journal 2Evidence of Ancient Hot Springs on Mars Detailed in Astrobiology Journal 3Corgenix Reports Second Quarter Fiscal 2009 Financial Results 2Corgenix Reports Second Quarter Fiscal 2009 Financial Results 3Corgenix Reports Second Quarter Fiscal 2009 Financial Results 4
(Date:12/16/2009)... new "Climate Knowledge and Innovation Community (Climate-KIC)" is a ... The Climate-KIC program brings together the expertise of world ... step-change in Europe,s innovation capacity to meet the climate ... prepare for a new low-carbon society. In responding to ... how we produce, distribute, and consume goods, and to ...
(Date:12/16/2009)... of water is a high priority for grape growers in the ... have to be irrigated to make it through the growing season. ... water applied to the vines zips right by the plants, hardly ... the water that is applied is lost below the vine rooting ... roots," said Eve Hinckley, who worked on the project for her ...
(Date:12/16/2009)... psyched up for contests, but when these rituals involve ... before and during events, they could be causing more ... the symptoms of an injury, not the injury itself," ... on musculoskeletal health and sports medicine. "They may allow ... level, but pain occurs for a reason. It is ...
Breaking Biology News(10 mins):Innovation boost to tackle climate change 2Innovation boost to tackle climate change 3Lost water of the Napa Valley vineyards 2Lost water of the Napa Valley vineyards 3Lost water of the Napa Valley vineyards 4NSAIDs: Take 'em early and often when competing? Think again 2American Heart Associations Scientific Sessions Media Alert 61378 1Alternative to Warfarin May Cut Risk of Bleeding 61375 1Alternative to Warfarin May Cut Risk of Bleeding 61375 2Largest gene study of childhood IBD identifies 5 new genes 10724 1Largest gene study of childhood IBD identifies 5 new genes 10724 2
... this, cells in your eye are transmitting information to your ... as hard to keep that brain alive. Every one of ... on an internal process called endocytosis to keep the flow ... an incredibly important life process, and now researchers at Weill ...
... step in cell migration, the movement of cells within ... immune response to invading pathogens, has been demonstrated by ... School of Medicine. Published in the March 27 online ... April print edition, the study describes how a the ...
... compiled the first atlas showing the locations of ... parts of the brain,develop ?and, in some cases, ... will accelerate research on brain tumors and,neurological diseases ... “transcription factors.?When these genes are altered, the,genes they ...
Other Biology News:Weill Cornell Research Reveals Secrets Of Trafficking Within Cells 2Weill Cornell Research Reveals Secrets Of Trafficking Within Cells 3Vital step in cellular migration described by UCSD medical researchers 2First 'atlas' of key brain genes could speed research on cancer, neurological diseases 2
karyopherin alpha2 (2G7)...
50 assays. Provides an easy system for rapid separation of cytosol and particulate fractions that are compatiable with downstream studies....
Eliminate electrical interference from any analog signal, without filtering. Ideal for electrophysiology applications like EKG, EMG, and EEGs. Removes 50/60hz noise and harmonics caused by grounding ...
... 400 Spun Columns, 10. *SizeSep 400 Spun ... 400 base pairs in length. - ... and pre-equilibrated in distilled water containing 0.15% Kathon ... ~ 400 base pairs. *Extremely useful ...
Biology Products: